Absolutys Biosciences’ precision medicine platform enables multiomics biomarkers remote monitoring and intelligence to foster equitable access to personalized cardiovascular prevention, management and therapy. A patient-centered, end-to-end platform that provides a cardiovascular signature and risk score based on real-time medical and lifestyle biomarkers. Our software-as-a-medical device allows remote-patient monitoring through home-based diagnostics and delivers evidence-based interventions. By increasing personalized patient engagement and physician decision support, the platform improves health outcomes, optimizes payer economics, increases HCP performance and fosters RWE-based innovation to democratize healthcare.
